Verrica Pharmaceuticals Inc. Sustainability Profile
Verrica Pharmaceuticals Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative treatments for skin diseases. Founded in 2018, Verrica has quickly established itself in the dermatology sector, particularly in the treatment of conditions such as molluscum contagiosum. The company’s flagship product, VP-102, is a unique topical therapy that utilises a proprietary formulation to effectively target viral skin infections. This innovative approach sets Verrica apart in a competitive market, positioning it as a key player in dermatological therapeutics. With a commitment to advancing patient care, Verrica Pharmaceuticals continues to make significant strides in the industry, aiming to improve the quality of life for those affected by challenging skin conditions.
DitchCarbon Score
How does Verrica Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Verrica Pharmaceuticals Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Verrica Pharmaceuticals Inc.'s reported carbon emissions
Verrica Pharmaceuticals Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures for Scope 1, Scope 2, and Scope 3 emissions. Consequently, there are no documented reduction targets or climate commitments available at this time. The company has not established any initiatives or pledges related to climate action, nor does it inherit emissions data from a parent or related organization. As such, Verrica Pharmaceuticals appears to be in the early stages of addressing its carbon footprint and climate impact within the pharmaceutical industry.
How Carbon Intensive is Verrica Pharmaceuticals Inc.'s Industry?
How Carbon Intensive is Verrica Pharmaceuticals Inc.'s Location?
Verrica Pharmaceuticals Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Verrica Pharmaceuticals Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.